Business development companies have tumbled in recent weeks and now offer some of the highest yields in the stock market. For investors with tolerance for risk and volatility, BDCs offer plenty of ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

Fears around the risk/reward associated with high-yield bonds have led to Paul Niven, head of multi-asset at Columbia Threadneedle, to reduce his exposure to the asset class. Previously keen on the ...

Gearbox has big plans for Borderlands 4’s next big patch. Gearbox associate creative director Grant Kao made this announcement on Twitter: @ProdigyXL (AKA creative director Graeme Timmins) and I have ...

Getting the best rate as a saver has been a little more difficult since the Federal Reserve started cutting its benchmark rate toward the end of 2024. Fed officials paused reductions throughout most ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Michael Egorov, founder of Curve Finance, has launched Yield Basis, a decentralized protocol built to provide sustainable bitcoin BTC $109,965.07 yield while eliminating impermanent loss (IL), one of ...